View all our research

For many reasons (e.g. side effects, treatment beliefs), women with breast cancer struggle to adhere to adjuvant (post-treatment) hormonal therapy (HT). This is…

Breast cancer is the third most commonly diagnosed cancer in Yorkshire, causing more than 800 deaths per year in the region. Breast screening is one of the key…

In Yorkshire, over 14,000 people die from advanced cancer each year, a number expected to rise up to 17,000 by 2030. 
In the weeks or months before they die, people…

Some patients with rectal cancer are not able to have it removed by surgery. They may suffer from symptoms as their cancer grows, including pain, diarrhoea and the…

People with cancer can experience distressing symptoms, worries and concerns from diagnosis to advanced disease; some get better supportive and palliative care than…

Detecting lung cancer through screening saves lives. 
The Yorkshire Lung Screening Trial (YLST) will test community-based lung cancer screening in mobile vans…

More people are diagnosed with and die from lung cancer in Hull than any other place in Yorkshire. 
The aim of this research programme is to improve earlier…

The first aim of this research programme is to improve care and achieve better outcomes for people with bowel cancer. 
The programme will develop new methods and…

Using an existing medication that slows prostate growth, Finasteride, this trial will test whether the medication can reduce the need for extensive surgery or…

The APPROACH trial, funded by Yorkshire Cancer Research and led by researchers at University College London, aims to test whether a physical activity mobile app can…

The way hospitals treat bowel cancer varies significantly across Yorkshire. The Bowel Cancer Improvement Programme, funded by Yorkshire Cancer Research, assesses…

Can giving specific groups of patients a course of chemotherapy before surgery help improve survival rates? Two international clinical trials which make up this…